Allergic Rhinitis Drugs News
Drugs
> Allergic Rhinitis DrugsAllergic Rhinitis Drugs News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Allergic Rhinitis Drugs News
- STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 27 Nov 2009 10:11 GMT
... approved it. Oralair(R) is an immunotherapy tablet aimed at patients suffering from severe rhinoconjunctivitis caused ... by grass pollens, inadequately controlled using symptomatic treatments (antihistamines, corticosteroids). "The European registration of Oralair(R) ... the dust mite immunotherapy tablet, Actair(R) in allergic rhinitis in adults during the first half ...
- Oxagen Raises £16M to Continue Clinical Development of CRTH2 Antagonist against Asthma 24 Nov 2009 16:51 GMT
... is an oral anti-inflammatory agent for the treatment of allergic disease and has completed Phase ... trials demonstrating efficacy in both asthma and allergic rhinitis. Oxagen is focused on the development ... is focused on the development of GPCR-targeting drugs against inflammatory diseases. The company has developed ...
- Clinical Trial Research: Research from Merck & Company, Inc. yields new data on clinical trial research 26 Nov 2009 05:56 GMT
... in controlled clinical studies of leukotriene modifier drugs have not been summarized. We sought to ... BRAE considered serious was 0.03% in both treatment groups. Reports of BRAEs were infrequent in ... 10010-1710, USA. Keywords: City:Wales, State:PA, Country:United States, Allergic Rhinitis, Allergies, Allergy Medicine, Antiarrhythmic, Asthma, Behavior, ...
- Financing Drug Discovery: Recent Deals 26 Nov 2009 09:19 GMT
... The company is focused on identifying and developing best- and first-in-class therapeutic candidates that target ... including sphingosine-1-phosphate receptor 1 (S1P1), for structure-based drug design. The company will also expand efforts into ... proof-of-concept (POC) studies in both asthma and allergic rhinitis. CRTH2, also known as DP2, is a ...
- ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 24 Nov 2009 23:25 GMT
... Beach, FL. In a poster presentation titled, "Treatment of Ocular Itching with Bepotastine Besilate Ophthalmic ... was approved by the U.S. Food and Drug Administration in September 2009 for the treatment of ... for systemic use in the treatment of allergic rhinitis since 2000 and urticaria/pruritus since 2002. It ...
- Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune Cat Allergy Therapy 23 Nov 2009 03:35 GMT
... ToleroMune Cat Allergy Therapy Study Identifies Optimal Treatment Approach for Late-Stage Development OXFORD, England, November 20/PRNewswire/ ... study in Canada, where 121 subjects with confirmed cat allergies were randomised to receive placebo ... opportunities. Over 150 million people suffer from allergic rhinitis in the US and Europe, and ...
- Oxagen Limited Raises 16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds 24 Nov 2009 09:52 GMT
... ABINGDON, UK--(BUSINESS WIRE)-- Oxagen Limited, a drug discovery and development company specializing in inflammation, ... proof-of-concept (POC) studies in both asthma and allergic rhinitis. CRTH2, also known as DP2 is a ... diseases. Oxagen's pipeline of novel small molecule drugs is based on targets validated in man. ...
- Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds 24 Nov 2009 09:53 GMT
... by Novartis Venture Funds )--Oxagen Limited, a drug discovery and development company specializing in inflammation, ... proof-of-concept (POC) studies in both asthma and allergic rhinitis. CRTH2, also known as DP2 is a ... diseases. Oxagen's pipeline of novel small molecule drugs is based on targets validated in man. ...
- Oxagen Limited Raises GBP 16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds 24 Nov 2009 10:50 GMT
... 2009 (BUSINESS WIRE) -- Oxagen Limited, a drug discovery and development company specializing in inflammation, ... proof-of-concept (POC) studies in both asthma and allergic rhinitis. CRTH2, also known as DP2 is a ... diseases. Oxagen's pipeline of novel small molecule drugs is based on targets validated in man. ...
- Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma 19 Nov 2009 13:32 GMT
... study will provide important information on the drug's potential to improve lung function and to ... are implicated in the pathogenesis of asthma, allergic rhinitis and other inflammatory disorders. AIR645 is a ... first in a new class of inhaled drugs that incorporate proprietary, second-generation antisense chemistry. College ...
- Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma Study to Assess Efficacy of Once-Weekly Inhaled Non-Steroidal Anti-Inflammatory in Suppressing Asthmatic Respo 19 Nov 2009 13:21 GMT
... study will provide important information on the drug's potential to improve lung function and to ... this study, and to ultimately providing improved treatment for asthmatic patients worldwide." More information on ... are implicated in the pathogenesis of asthma, allergic rhinitis and other inflammatory disorders. AIR645 is a ...
- Fatigue and Drowsiness: Everyday Exhaustion and Beyond 19 Nov 2009 14:50 GMT
... Etiologies include premenstrual syndrome, premenstrual dysphoric disorder, allergic rhinitis, asthma, anemias, hypo- or hyperthyroidism, Addison's ... and obstructive sleep apnea. Alcohol and other drugs of abuse (e.g., cocaine, narcotics) cause fatigue, ... as the eight symptoms that define CFS. Treatment options for CFS are diverse and of ...
- Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy The 20 Nov 2009 09:40 GMT
... ToleroMune(R) Cat Allergy Therapy Study Identifies Optimal Treatment Approach for Late-Stage Development OXFORD, England, November 20 ... study in Canada, where 121 subjects with confirmed cat allergies were randomised to receive placebo ... opportunities. Over 150 million people suffer from allergic rhinitis in the US and Europe, and ...
- Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy 20 Nov 2009 09:41 GMT
... ToleroMune(R) Cat Allergy Therapy Study Identifies Optimal Treatment Approach for Late-Stage Development /PRNewswire/ -- Circassia Ltd, ... sufferers' symptoms. , where 121 subjects with confirmed cat allergies were randomised to receive placebo ... opportunities. Over 150 million people suffer from allergic rhinitis in the US and , and ...
- Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy 20 Nov 2009 09:41 GMT
... cat allergy immunotherapy, showed that Circassia's ToleroMune treatment was extremely well tolerated and greatly reduced sufferers' ... study in Canada, where 121 subjects with confirmed cat allergies were randomised to receive placebo ... opportunities. Over 150 million people suffer from allergic rhinitis in the US and Europe, and ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
nytimes.com:
bbc.co.uk:
guardian.co.uk:
msnbc.msn.com: